AEON BIOPHARMA INC
(NYSE Mkt: AEON)

AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.

1.580

-0.050 (-3.07%)
Range 1.440 - 1.680   (16.67%)
Open 1.630
Previous Close 1.630
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 105,757
Value -
Remark
Delayed prices. Updated at 16 May 2024 04:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis